search
Back to results

ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation (ICE)

Primary Purpose

Atrial Fibrillation

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Biosense Webster irrigated tip catheter
Biosense Webster irrigated tip catheter
Pulmonary vein isolation
ICE catheter placed through one of two existing 8F sheaths
Sponsored by
Gregory Jones
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Atrial Fibrillation focused on measuring Atrial Fibrillation

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 18 to 80 years
  • Recommended for radiofrequency ablation of nonvalvular atrial fibrillation

Exclusion Criteria:

  • none

Sites / Locations

  • Wellmont CVA Heart Institute

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Study arm

Control arm

Arm Description

The study arm group will have the ICE catheter placed through one of two existing 8F sheaths already in the left atrium. The ICE catheter will be exchanged in the sheath utilizing the lasso multipolar mapping catheter during left pulmonary vein ablation lines. During exchange, suction and irrigation techniques will be utilized to avoid any air or thrombus embolization. All patients will have standard anticoagulation during the procedure with heparin infusion adjusted to an activated clotting time (ACT) of 350-400. The left sided ICE catheter will be adjusted to visualize left sided structures, ablation tip and tissue interface, and adjacent noncardiac structures such as the esophagus during radiofrequency ablation of the left pulmonary vein system.

The control arm group will receive standard pulmonary vein isolation (PVI) procedure utilizing intracardiac guided ultrasound (ICE) placed within the right atrium via the femoral vein.

Outcomes

Primary Outcome Measures

number of lesions requiring ablation to obtain Electrical Isolation PV System
to assess the number of lesions requiring ablation to obtain Electrical Isolation PV system

Secondary Outcome Measures

to assess number of lesions to obtain Electrical Isolation PV system
Evaluate the time required to obtain electrical isolation of PV system

Full Information

First Posted
December 31, 2013
Last Updated
April 23, 2018
Sponsor
Gregory Jones
Collaborators
Biosense Webster, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT02028143
Brief Title
ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation
Acronym
ICE
Official Title
ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation
Study Type
Interventional

2. Study Status

Record Verification Date
April 2018
Overall Recruitment Status
Completed
Study Start Date
November 2013 (undefined)
Primary Completion Date
January 2015 (Actual)
Study Completion Date
January 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Gregory Jones
Collaborators
Biosense Webster, Inc.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Imaging Real Time within the Left atrial chamber Enhances safety and efficacy of Radiofrequency Ablation of Atrial Fibrillation
Detailed Description
Atrial fibrillation is the most common rhythm disturbance affecting the human population. Its prevalence increases with age and can be found in >8% of humans over the age of eighty; Radiofrequency ablation for drug refractory nonvalvular atrial fibrillation has become a common therapy available to patients. It has been shown to be both efficacious and cost effective; The standard approach to atrial fibrillation involves electrical isolation of the pulmonary veins (PVI) from the rest of the atrium chamber. This involves moving a 3.5mm tip ablation catheter point to point around the PV structures until an encircling ablation line is formed. This can be made difficult by not knowing if the tip is in good contact with the atrial tissue. In addition the esophagus is a posterior lying structure and injury to the esophagus by ablating the overlying tissue has been reported, at times fatal; Currently, intracardiac imaging of the left atrium has FDA approval in the right atrial chamber. This leads to difficulty in visualizing tip tissue interface, and important left sided structures such as carina, ligaments, and esophagus. By placing the tip of the ICE catheter in the left atrium, enhanced visualization of the tip tissue interface may lead to more effective ablation points, fewer needed ablation points, and enhanced safety by avoiding placement over adjacent noncardiac structures.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation
Keywords
Atrial Fibrillation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Study arm
Arm Type
Experimental
Arm Description
The study arm group will have the ICE catheter placed through one of two existing 8F sheaths already in the left atrium. The ICE catheter will be exchanged in the sheath utilizing the lasso multipolar mapping catheter during left pulmonary vein ablation lines. During exchange, suction and irrigation techniques will be utilized to avoid any air or thrombus embolization. All patients will have standard anticoagulation during the procedure with heparin infusion adjusted to an activated clotting time (ACT) of 350-400. The left sided ICE catheter will be adjusted to visualize left sided structures, ablation tip and tissue interface, and adjacent noncardiac structures such as the esophagus during radiofrequency ablation of the left pulmonary vein system.
Arm Title
Control arm
Arm Type
Active Comparator
Arm Description
The control arm group will receive standard pulmonary vein isolation (PVI) procedure utilizing intracardiac guided ultrasound (ICE) placed within the right atrium via the femoral vein.
Intervention Type
Device
Intervention Name(s)
Biosense Webster irrigated tip catheter
Other Intervention Name(s)
3.5mm Biosense Webster irrigated tip catheter.
Intervention Description
The second group (study group) will have the ICE catheter placed through one of two existing 8F sheaths already in the left atrium. The ICE catheter will be exchanged in the sheath utilizing the lasso multipolar mapping catheter during left pulmonary vein ablation lines. During exchange, suction and irrigation techniques will be utilized to avoid any air or thrombus embolization. All patients will have standard anticoagulation during the procedure with heparin infusion adjusted to an activated clotting time (ACT) of 350-400. The left sided ICE catheter will be adjusted to visualize left sided structures, ablation tip and tissue interface, and adjacent noncardiac structures such as the esophagus during radiofrequency ablation of the left pulmonary vein system.
Intervention Type
Device
Intervention Name(s)
Biosense Webster irrigated tip catheter
Other Intervention Name(s)
3.5mm Biosense Webster irrigated tip catheter.
Intervention Description
Group 1 will receive standard pulmonary vein isolation (PVI) procedure utilizing intracardiac guided ultrasound (ICE) placed within the right atrium via the femoral vein.
Intervention Type
Procedure
Intervention Name(s)
Pulmonary vein isolation
Intervention Type
Procedure
Intervention Name(s)
ICE catheter placed through one of two existing 8F sheaths
Primary Outcome Measure Information:
Title
number of lesions requiring ablation to obtain Electrical Isolation PV System
Description
to assess the number of lesions requiring ablation to obtain Electrical Isolation PV system
Time Frame
during procedure
Secondary Outcome Measure Information:
Title
to assess number of lesions to obtain Electrical Isolation PV system
Description
Evaluate the time required to obtain electrical isolation of PV system
Time Frame
during procedure
Other Pre-specified Outcome Measures:
Title
Safety-Cardiac perforation, emboli, fistula formation
Description
evaluate the use of ultrasound catheter for adverse events such as cardiac perforation, emboli or fistula formation
Time Frame
during procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18 to 80 years Recommended for radiofrequency ablation of nonvalvular atrial fibrillation Exclusion Criteria: none
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gregory Jones, MD
Organizational Affiliation
Wellmont CVA Heart Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Wellmont CVA Heart Institute
City
Kingsport
State/Province
Tennessee
ZIP/Postal Code
37660
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation

We'll reach out to this number within 24 hrs